Vimarsana
Biggest News Aggregation in the World

Page 4 - Injectable Solutions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Injectable Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Injectable Solutions Today - Breaking & Trending Today

Endo International plc: Endo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use Vials - Vimarsana News

Endo International plc: Endo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use Vials

Only ready-to-use (RTU) liquid format of bivalirudin expected to begin shipping in summer 2023RTU bivalirudin injection does not require reconstitution, dilution or mixing, which helps increase

Endo Announces Launch of Argatroban Injection Through Premier's ProRx® Private-Label Program - Vimarsana News

Endo Announces Launch of Argatroban Injection Through Premier's ProRx® Private-Label Program

/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that its Par Sterile Products business has begun shipping argatroban injection to...

Endo International plc: Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral Suspension - Vimarsana News

Endo International plc: Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral Suspension

DUBLIN, April 3, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping the authorized generic

Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral Suspension - Vimarsana News

Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral Suspension

/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping the...

Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral Suspension - Vimarsana News

Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral Suspension

DUBLIN, April 3, 2023 /PRNewswire/ -- Endo International plc announced today that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping the authorized generic version of... | June 21, 2023